कोशिश गोल्ड - मुक्त
Biocon Biologics gets USFDA nod
Mint Hyderabad
|April 11, 2025
Biocon Biologics on Thursday said it has received an approval from the US health regulator to market a cancer treatment biosimilar product.
The company, a subsidiary of Biocon Ltd, has received approval from the US Food and Drug Administration (USFDA) for Jobevne (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous use, the company said in a regulatory filing.
यह कहानी Mint Hyderabad के April 11, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Hyderabad से और कहानियाँ
Mint Hyderabad
Xi warns Trump that Taiwan differences may lead to feud
The pair met for about two hours behind closed doors at the Great Hall of the People
4 mins
May 15, 2026
Mint Hyderabad
Airtel charts path to higher Africa stake, succession plan
Bharti Airtel Ltd plans to raise its stake in Airtel Africa Plc to as much as 90% over the coming years, chairman Sunil Bharti Mittal said on Thursday, outlining a long-term capital allocation and ownership roadmap as he prepares for a generational transition within the group.
1 mins
May 15, 2026
Mint Hyderabad
JSW Steel raises capacity target sharply amid strong FY26 show
Sajjan Jindal-led JSW Steel plans to nearly double its capacity to about 80 million tonnes per annum (mtpa) by 2031 through aggressive brownfield expansion and joint ventures, positioning India’s largest steelmaker among the world’s biggest producers.
2 mins
May 15, 2026
Mint Hyderabad
How factor funds help investors merge various investment styles
Factor funds can work best as a diversification layer for those who have built a foundation through traditional funds
4 mins
May 15, 2026
Mint Hyderabad
Is austerity India’s best option in the face of an economic shock?
Official spending cutbacks can spell recessions if overdone. Other forms need impact analysis too
3 mins
May 15, 2026
Mint Hyderabad
What we can expect of the US Fed under Warsh
The change of guard at the Federal Reserve, with Trump’s appointee taking over, could have significant implications for the global economy. Other central banks will be watching closely
2 mins
May 15, 2026
Mint Hyderabad
Bond yield surge dents PSU banks’ non-core income
Rising government bond yields hit banks’ treasury income in the March quarter (Q4FY26), dragging down non-core earnings, especially at public sector lenders. Analysts now expect the pressure to intensify in the June quarter after an oil-driven spike in bond yields following the West Asia conflict.
3 mins
May 15, 2026
Mint Hyderabad
Manipal Hospitals to market $1 billion IPO
Manipal Health Enterprises Pvt, which runs the Manipal Hospitals chain, is set to begin formal marketing as early as next week for its planned initial public offering to raise more than $1 billion, according to people familiar with the matter.
1 min
May 15, 2026
Mint Hyderabad
Warsh confirmed to lead Fed in narrowest vote ever
The US Senate narrowly confirmed Kevin Warsh as chair of the Federal Reserve (Fed), setting up the most controversial leadership transition at the US central bank in decades and a test of its political independence.
1 min
May 15, 2026
Mint Hyderabad
Bajaj eyes entry into healthcare
The Bajaj group will diversify into the healthcare business next and plans to invest over ₹2,000 crore in Pune over the next three years, a top official has said.
1 min
May 15, 2026
Listen
Translate
Change font size